論文（邦文）
- ゲノム医療と前立腺癌―現状と未来の展望―
- 土肥洋一郎
西日本泌尿器科学会雑誌 第87巻増刊号2（2025年6月） P124-125 - 「内分泌腫瘍の過剰診断・過剰治療を考える」 前立腺がんに対する監視療法の現況と課題
- 加藤琢磨
日本内分泌外科学会雑誌（2434-6535）41巻4号 Page240-244 - 【今のうちにしっかり理解 最新の前立腺癌診療と近未来予想図】監視療法におけるMRI、バイオマーカーの有効性
- 加藤琢磨
臨床泌尿器科（0385-2393）79巻1号 Page34-39（2025.01） - 希少糖D-alloseの抗癌メカニズムと癌治療への応用に向けて
- 阿部陽平、田岡利宜也、アクラム・ホセイン、張 霞、杉元幹史
Glycoforum 2025 Vol.28 (2), A6） DOI - 進行性・転移性尿路上皮癌の新展開ー治療を選べる時代へー
- 田岡利宜也、川合剛人、菊地栄次
泌尿器外科 38(1):1-10,2025 - 「日本泌尿器腫瘍学会 第10回学術集会」 印象記
- 田岡利宜也
臨床泌尿器科 79巻2号190-191,2025. - 進行尿路上皮癌に対する治療戦略の近未来予想: 3年後はこうなる
- 田岡利宜也、杉元幹史
西日本泌尿器科 87:192-193,2025 - TURBT完全攻略: TURBTにSurgical Checklist は本当に必要か?
- 田岡利宜也、杉元幹史
泌尿器外科 38(10):1024-1030,2025.
論文（英文）
- Rare Sugar D-allose in Cancer Therapy as a Revolutionary Approach with Promising Future Insights
- Rikiya Taoka, Akram Hossain, Yohei Abe, Zhang Xia, and Mikio Sugimoto
Glycoforum 2025 Vol.28 (2), A6） DOI - Impact of Contrast Media on Cytological Evaluation of Urothelial Carcinoma: An In vitro Study with Relevance to Upper Tract Diagnostics
- Yuki Matsuoka, Rikiya Taoka, Kazuya Katakura, Zhang Xia, Akram Hossain, Hirohito Naito, Satoshi Harada, Reiji Haba, Mikio Sugimoto
Journal of Cytology 42(4):204-208,2025. - Shifts in Diagnostic Approaches for Prostate Cancer: Impact of MRI-Informed Biopsies on Low-Risk Cancer Detection
- Yoichiro Tohi, Takuma Kato, Kengo Fujiwara, Satoshi Harada, Asuka Kaji, Kana Kohashiguchi, Yohei Abe, Hirohito Naito, Homare Okazoe, Rikiya Taoka, Nobufumi Ueda, Mikio Sugimoto
Int J Urol. 2025 Aug 3. doi: 10.1111/iju.70193. - Temporal changes in the urologist’s practice behaviour of active surveillance for prostate cancer: analysis of prospective observational study cohort.
- Yoichiro Tohi, Akira Yokomizo, Ryuji Matsumoto, Keiichiro Mori, Shinichi Sakamoto, Masaki Shiota, Yoshitaka Sekine, Toru Kanno, Takuma Kato, Hiroshi Fukuhara, Yasuyuki Sakai, Yasuo Kohjimoto, Iori Matsuda, Takayuki Goto, Norihiko Kawamura, Yoshito Kusuhara, Katsuyoshi Hashine, Hideyasu Tsumura, Yushi Naito, Mikio Sugimoto ; PRIAS-JAPAN
Jpn J Clin Oncol. 2025 Oct 7;55(10):1170-1176. - Nerve-Sparing Robotic-Assisted Radical Prostatectomy Based on the Absence of Prostate Imaging-Reporting and Data System ≥3 or Biopsy Gleason Pattern ≥4 in the Peripheral Zone.
- Yoichiro Tohi, Hiroyuki Tsunemori, Kengo Fujiwara, Takuma Kato, Kana Kohashiguchi, Asuka Kaji, Satoshi Harada, Yohei Abe, Hirohito Naito and Homare Okazoe
Cancers (Basel). 2025 Mar 12;17(6):962. - Overuse of imaging in prostate cancer staging
- Yoichiro Tohi, Takuma Kato, Kana Kohashiguchi, Asuka Kaji, Kengo Fujiwara, Satoshi Harada, Yohei Abe, Hirohito Naito, Homare Okazoe, Rikiya Taoka, Nobufumi Ueda, Mikio Sugimoto
Int J Urol. 2025 Feb 3. doi: 10.1111/iju.70003 - Nomogram predicting the outcome of salvage radiation therapy for prostate-specific assessment failure following radical prostatectomy: an exploratory analysis of a randomized, multicenter, open-label, phase 3 trial (JCOG0401)
- Yoichiro Tohi, Akira Yokomizo, Takahiro Kimura, Masashi Wakabayashi, Masaki Shiota, Keiichiro Mori, Takuma Kato, Toyonori Tsuzuki, Masashi Kato, Keita Sasaki, Takashi Kawahara, Masatoshi Eto, Hiroyuki Nishiyama, Hiroshi Kitamura, Mikio Sugimoto
Int J Clin Oncol. 2025 Mar 8. doi: 10.1007/s10147-025-02714-4. - Real-world clinical usage and efficacy of apalutamide in men with nonmetastatic castration-resistant prostate cancer: a multi-institutional study in the CsJUC.
- Yoichiro Tohi, Keita Kobayashi, Kei Daizumoto, Yohei Sekino, Hideo Fukuhara, Heima Niigawa, Satoshi Katayama, Ryutaro Shimizu, Atsushi Takamoto, Kenichi Nishimura, Taichi Nagami, Yushi Hayashida, Hiromi Hirama, Koji Shiraishi, Ryotaro Tomida, Kohei Kobatake, Keiji Inoue, Yoshiyuki Miyaji, Kensuke Bekku, Shuichi Morizane, Noriyoshi Miura, Koichiro Wada, Mikio Sugimoto
Jpn J Clin Oncol. 2025 Feb 2:hyaf025. doi: 10.1093/jjco/hyaf025. - Real-World Clinical Outcomes of Darolutamide in Older Patients With Non-metastatic Castration-Resistant Prostate Cancer: A Multi-institutional Comparative Analysis of Efficacy and Tolerability.
- Yoichiro Tohi, Takuma Kato, Kengo Fujiwara , Yushi Hayashida , Yuki Matsuoka, Hiromi Hirama, Toshifumi Yano, Hiroyuki Tsunemori, Hironobu Arai, Mikio Sugimoto
Cureus 17(11): e97911. - Reassessment of approaches to prostate biopsy in the era of magnetic resonance imaging-targeted biopsy: insights from the ProBE-PC study
- Yoichiro Tohi, Takuma Kato, Mikio Sugimoto
Transl Androl Urol. 2025 Feb 28;14(2):205-209. doi: 10.21037/tau-2024-707. - Enfortumab vedotin promotes PD-L1 expression in urothelial carcinoma via NF-κB and STAT3 pathways highlighting mechanisms of immune evasion and potential for combination therapy
- Hirohito Naito, Rikiya Taoka, Xia Zhang, Akram Hossain, Yohei Abe, Mikio Sugimoto
BMC Immunol. 2025 Sep 25;26(1):70. doi: 10.1186/s12865-025-00751-2. - Accuracy of photodynamic diagnosis for non-muscle-invasive bladder cancer: exploratory analysis of anatomical locations and tumor types using data from a prospective, single-arm, multicenter phase III trial
- Rikiya Taoka, Kiyohide Fujimoto, Keiji Inoue, Toyonori Tsuzuki, Mototsugu Oya, Mikio Sugimoto
Int J Urol. 2025 Mar;32(3):319-321. - Efficacy of photodynamic diagnosis for non-muscle invasive bladder cancer: exploratory subject-based analysis in a prospective, single-arm, multicenter phase III trial
- Rikiya Taoka, Kiyohide Fujimoto, Keiji Inoue, Toyonori Tsuzuki, Mototsugu Oya, Mikio Sugimoto
Photodiagnosis Photodyn Ther. 2025 Mar 12;53:104554. - Effect of extending the period from oral administration of 5-aminolevulinic acid hydrochloride to photodynamic diagnosis during transurethral resection for non-muscle invasive bladder cancer on diagnostic accuracy and safety: a single-arm multicenter phase III trial
- Taoka R, Fukuhara H, Miyake M, Kobayashi K, Ikeda A, Kanao K, Komai Y, Fujiwara R, Sato Y, Sugimoto M, Tsuzuki T, Fujimoto K, Inoue K, Oya M.
Int J Clin Oncol. 2025 Jan;30(1):110-120. doi: 10.1007/s10147-024-02638-5. - Predictive Factors for Gastrointestinal and Hepatic Adverse Events during 5-Aminolevulinic Acid‒ Guided Photodynamic Diagnosis in Bladder Cancer: Exploratory Analysis of the Phase III SPP2C102 Trial
- Taoka R, Fukuhara H, Miyake M, Kobayashi K, Ikeda A, Kanao K, Komai Y, Fujiwara R, Sato Y, Sugimoto M, Tsuzuki T, Fujimoto K, Inoue K, Oya M.
Int J Urol. in press - Prognosis Based on Postoperative PSA Levels and Treatment in Lymph Node-Positive Prostate Cancer
- Tokiyoshi Tanegashima, Masaki Shiota, Takahiro Kimura, Dai Takamatsu, Yoshiyuki Matsui, Akira Yokomizo, Ryoichi Saito, Shuichi Morizane, Makito Miyake, Masakazu Tsutsumi, Yoshiyuki Yamamoto, Kojiro Tashiro, Ryotaro Tomida, Kohei Edamura, Shintaro Narita, Takahiro Yamaguchi, Takashi Kasahara, Kohei Hashimoto, Masashi Kato, Takayuki Yoshino, Shusuke Akamatsu, Akihiro Matsukawa, Tomoyuki Kaneko, Ryuji Matsumoto, Akira Joraku, Manabu Kato, Toshihiro Saito, Takuma Kato, Shuichi Tatarano, Shinichi Sakamoto, Hidenori Kanno, Naoki Terada, Naotaka Nishiyama, Hiroshi Kitamura, Masatoshi Eto; Japanese Urological Oncology Group
Int J Clin Oncol. 2024 Oct;29(10):1586-1593. doi: 10.1007/s10147-024-02580-6. Epub 2024 Jul 8. - Risk Model for Lymph Node-positive Prostate Cancer after Radical Prostatectomy
- Kojiro Tashiro, Keiichiro Mori, Masaki Shiota, Wataru Fukuokaya, Dai Takamatsu, Yoshiyuki Matsui, Ryotaro Tomida, Ryoichi Saito, Akira Yokomizo, Masakazu Tsutsumi, Yoshiyuki Yamamoto, Kohei Edamura, Makito Miyake, Shuichi Morizane, Takayuki Yoshino, Akihiro Matsukawa, Ryuji Matsumoto, Takashi Kasahara, Shintaro Narita, Hiroaki Matsumoto, Kohei Hashimoto, Masashi Kato, Shusuke Akamatsu, Akira Joraku, Takahiro Yamaguchi, Manabu Kato, Toshihiro Saito, Takuma Kato, Tomoyuki Kaneko, Atsushi Takahashi, Hideki Enokida, Shinichi Sakamoto, Naotaka Nishiyama, Naoki Terada, Hiroshi Kitamura, Masatoshi Eto, Takahiro Kimura; on behalf of the Japanese Urological Oncology Group
Int J Urol. 2025 Oct;32(10):1386-1392. doi: 10.1111/iju.70149. - Validation of five prognostic models treated with axitinib beyond first-line combination therapy for metastatic renal cell carcinoma: A Japanese multicenter retrospective study.
- Hiroshi Kikuchi, Takahiro Osawa, Yuto Matsushita, Takahiro Kojima, Tomokazu Sazuka, Shingo Hatakeyama, Keisuke Goto, Kazuyuki Numakura, Kazutoshi Yamana, Shuya Kandori, Kosuke Ueda, Hajime Tanaka, Toshifumi Kurahashi, Yukari Bando, Takahiro Kimura, Naotaka Nishiyama, Takuma Kato, Hiroaki Hara, Yoichi Ito, Hiroshi Kitamura, Hideaki Miyake, Nobuo Shinohara
Jpn J Clin Oncol. 2025 Apr 26;55(5):531-538. doi: 10.1093/jjco/hyaf018. - Long-term outcomes of active surveillance for Grade Group 1 prostate cancer and the impact of the use of MRI on overtreatment
- Ivo I de Vos, Cristina Marenghi, Fabio Badenchini, Egbert R Boevé, Francisco Lozano-Uruñuela, Markus Graefen, Antti S Rannikko, Frederic Staerman, Mikio Sugimoto, Takuma Kato, Diederik M Somford, Mark Frydenberg, Chris H Bangma, Sebastiaan Remmers, Monique J Roobol; Prostate Cancer Research International: Active Surveillance (PRIAS) consortium
BJU Int. 2025 Aug;136(2):245-253. doi: 10.1111/bju.16727. - Impact of Impaired Renal Function on the Efficacy and Safety of Second-Line Tyrosine Kinase Inverser Therapy After First-Line Immuno-Oncology Combination Therapy in Metastatic Renal Cell Carcinoma: A Japanese Multicenter Retrospective Study
- Naoki Fujita, Yuto Matsushita, Takahiro Kojima, Yukari Bando, Takahiro Osawa, Tomokazu Sazuka, Keisuke Goto, Kazuyuki Numakura, Kazutoshi Yamana, Shuya Kandori, Yoshihide Kawasaki, Takuma Kato, Makito Miyake, Kazutoshi Fujita, Kosuke Ueda, Hajime Tanaka, Ryotaro Tomida, Hiroshi Kitamura, Hideaki Miyake, Shingo Hatakeyama; Japanese Urological Oncology Group
Int J Urol. 2025 Oct;32(10):1506-1517. doi: 10.1111/iju.70172. - Impact of Body Mass Index on the Efficacy of Immune Combination Therapy in Metastatic Renal Cell Carcinoma: A Multicenter Study in Japan
- Toshiki Anami, Takanobu Motoshima, Yuto Matsushita, Takahiro Kojima, Shimpei Yamashita, Hisanori Taniguchi, Keisuke Monji, Ryo Ishiyama, Yoshihide Kawasaki, Takuma Kato, Shuichi Tatarano, Kimihiko Masui, Eijiro Nakamura, Tomoyuki Kaneko, Makito Miyake, Hiroshi Kitamura, Hideaki Miyake, Tomomi Kamba; Japan Urological Oncology Group
Int J Oncol. 2025 Oct;30(10):2079-2086. - An inadequate number of first-line chemotherapy cycles provides poor survival outcomes in patients with metastatic urothelial carcinoma receiving avelumab maintenance: results from the chu-shikoku Japan urological consortium
- Satoshi Katayama, Takehiro Iwata, Shingo Nishimura, Kensuke Bekku, Keita Kobayashi, Nakanori Fujii, Kenichi Nishimura, Noriyoshi Miura, Yoichiro Tohi, Takuma Kato, Shinkuro Yamamoto, Hideo Fukuhara, Atsushi Takamoto, Ryutaro Shimizu, Shuichi Morizane, Yutaro Sasaki, Kei Daizumoto, Taichi Nagami, Koichiro Wada, Motoo Araki; Chu-shikoku Japan Urological Consortium
Jpn J Clin Oncol. 2025 Oct 22:hyaf163. doi: 10.1093/jjco/hyaf163. Online ahead of print. - Effectiveness and Safety of Second-line Tyrosine Kinase Inhibitors After Discontinuation of First-line Immune-oncology Combination Therapy Because of Adverse Events in the Patients With Metastatic Renal Cell Carcinoma
- Masayuki Takahashi, Yuto Matsushita, Takahiro Kojima, Takahiro Osawa, Tomokazu Sazuka, Shingo Hatakeyama, Keisuke Goto, Kazuyuki Numakura, Kazutoshi Yamana, Shuya Kandori, Kazutoshi Fujita, Kosuke Ueda, Hajime Tanaka, Ryotaro Tomida, Toshifumi Kurahashi, Yukari Bando, Takahiro Kimura, Naotaka Nishiyama, Shimpei Yamashita, Hisanori Taniguchi, Keisuke Monji, Ryo Ishiyama, Yoshihide Kawasaki, Takuma Kato, Shuichi Tatarano, Kimihiko Masui, Eijiro Nakamura, Tomoyuki Kaneko, Makito Miyake, Goshi Kitano, Takanobu Motoshima, Yusuke Shiraishi, Satoru Kira, Takaya Murashima, Hiroaki Hara, Masafumi Matsumura, Hiroshi Kitamura, Hideaki Miyake, Junya Furukawa; Japanese Urological Oncology Group
Clin Genitourin Cancer. 2025 Jun;23(3):102322. - Active Surveillance in Prostate Cancer With Intermediate-Risk Features: The PRIAS-JAPAN Study
- Leandro Blas, Masaki Shiota, Takuma Kato, Ryuji Matsumoto, Yoichiro Tohi, Shinichi Sakamoto, Akira Yokomizo, Takahiro Kimura, Junya Furukawa, Sunao Shoji, Haruki Kume, Takayuki Goto, Yoshitaka Sekine, Yasuyuki Sakai, Yoh Matsuoka, Nobuyuki Hinata, Toshiyuki Kamoto, Naoki Terada, Shusuke Akamatsu, Mikio Sugimoto, Masatoshi Eto
Int J Urol. 2025 Jul;32(7):823-827. doi: 10.1111/iju.70063. Epub 2025 Apr 7. - Clinically Informed Intermediate Reasoning Enables Generalizable Prognostication of Prostate Cancer through Machine Learning in Limited Settings
- Jun Akatsuka, Kotaro Tsutsumi, Mami Takadate, Yasushi Numata, Hiromu Morikawa, Atsushi Marugame, Hayato Takeda, Yuki Endo, Yuka Toyama, Takayuki Takahashi, Kaori Ono, Junya Iwazaki, Ryuji Ohashi, Akira Shimizu, Tomoharu Kiyuna, Maki Ogura, Masao Ueki, Takuma Kato, Toshiyuki China, Mikio Sugimoto, Hisamitsu Ide, Naoto Sassa, Naonori Ueda, Shigeo Horie, Toyonori Tsuzuki, Go Kimura, Yukihiro Kondo, Yoichiro Yamamoto
Digital medicine on line ahead of print - Needlestick Injury During Urological Surgery: A 15-Year Review From a Multi-Institutional Study in the Chugoku-Shikoku Japan Urological Consortium
- Yutaro Sasaki, Satoshi Katayama, Yoichiro Tohi, Keita Kobayashi, Kenichi Nishimura, Shinkuro Yamamoto, Heima Niigawa, Taisuke Jo, Kei Daizumoto, Hirohito Naito, Ryotaro Tomida, Shingo Nishimura, Takuma Kato, Kensuke Bekku, Noriyoshi Miura, Tomoya Fukawa, Koji Shiraishi, Keiji Inoue, Junya Furukawa
Int J Urol. 2025 Sep 24. doi: 10.1111/iju.70242. Online ahead of print. - Impact of lymph-node dissection during radical cystectomy for non-muscle-invasive bladder cancer: Japanese multicenter retrospective study
- Tomokazu Sazuka, Rikiya Taoka, Jun Miki, Ryoichi Saito, Wataru Fukuokaya, Yoshiyuki Matsui, Shingo Hatakeyama, Takashi Kawahara, Ayumu Matsuda, Taketo Kawai, Minoru Kato, Takeshi Sano, Fumihiko Urabe, Soki Kashima, Hirohito Naito, Yoji Murakami, Makito Miyake, Kei Daizumoto, Yuto Matsushita, Takuji Hayashi, Junichi Inokuchi, Yusuke Sugino, Kenichiro Shiga, Noriya Yamaguchi, Shingo Yamamoto, Keiji Yasue, Takashige Abe, Shotaro Nakanishi, Katsuyoshi Hashine, Atsuro Sawada, Kiyoaki Nishihara, Hiroaki Matsumoto, Shuichi Tatarano, Koichiro Wada, Sho Sekito, Ryo Maruyama, Naotaka Nishiyama, Hiroyuki Nishiyama, Hiroshi Kitamura, Tomohiko Ichikawa
Int J Clin Oncol. 2025 Jul;30(7):1417-1425. - Efficacy of cisplatin-based neoadjuvant chemotherapy and risk factors for residual extravesical disease in muscle-invasive bladder cancer: insights from a nationwide cohort
- Saito R, Taoka R, Miki J, Fukuokaya W, Matsui Y, Hatakeyama S, Kawahara T, Matsuda A, Kawai T, Sazuka T, Kato M, Sano T, Urabe F, Kashima S, Naito H, Murakami Y, Miyake M, Daizumoto K, Matsushita Y, Hayashi T, Inokuchi J, Sugino Y, Shiga K, Yamaguchi N, Yamamoto S, Yasue K, Abe T, Nakanishi S, Hashine K, Fujii M, Nishihara K, Matsumoto H, Tatarano S, Wada K, Sekito S, Maruyama R, Nishiyama N, Nishiyama H, Kitamura H, Kinoshita H; Japan Urological Oncology Group.
Int J Clin Oncol. 2025 Oct;30(10):2106-2117. doi: 10.1007/s10147-025-02833-y. - Effects of the Number of Neoadjuvant Cycles and Addition of Adjuvant Chemotherapy on the Prognosis of Muscle-Invasive Bladder Cancer Treated With Radical Cystectomy
- Hatakeyama S, Taoka R, Miki J, Saito R, Fukuokaya W, Matsui Y, Kawahara T, Matsuda A, Kawai T, Kato M, Sazuka T, Sano T, Urabe F, Kashima S, Naito H, Murakami Y, Miyake M, Daizumoto K, Matsushita Y, Hayashi T, Inokuchi J, Sugino Y, Shiga KI, Yamaguchi N, Taguchi M, Yasue K, Abe T, Nakanishi S, Hashine K, Fujii M, Nishihara K, Matsumoto H, Tatarano S, Wada K, Sekito S, Maruyama R, Nishiyama N, Nishiyama H, Kitamura H, Ohyama C; Japanese Urological Oncology Group.
Cancer Med.2025 May;14(9):e70782. doi: 10.1002/cam4.70782. - Stage III substaging and outcomes in patients with bladder cancer undergoing radical cystectomy
- Hara S, Fukuokaya W, Miki J, Taoka R, Saito R, Matsui Y, Hatakeyama S, Kawahara T, Matsuda A, Kawai T, Kato M, Sazuka T, Sano T, Urabe F, Kashima S, Naito H, Murakami Y, Miyake M, Daizumoto K, Matsushita Y, Hayashi T, Inokuchi J, Sugino Y, Shiga K, Yamaguchi N, Yamamoto S, Yasue K, Abe T, Nakanishi S, Hashine K, Fujii M, Nishihara K, Matsumoto H, Tatarano S, Wada K, Sekito S, Maruyama R, Nishiyama N, Nishiyama H, Kitamura H, Kimura T; Japan Urological Oncology Group.
Int J Urol. 2025 May;32(5):544-552. doi: 10.1111/iju.70005. Epub 2025 Feb 5. - A Multicenter Retrospective Study of Avelumab First-Line Maintenance and Subsequent Therapies for Locally Advanced and Metastatic Urothelial Carcinoma: Subgroup Analysis of First-Line Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, and Gemcitabine Plus Cisplatin in the Japan AVElumab MAintenance and Continuous Treatment Study (JAVEMACS)
- Ikeda M, Fujimoto K, Miura N, Taoka R, Nishihara K, Ikarashi D, Naito S, Shimizu F, Fujihara A, Shono M, Nakagawa T, Kikuchi E.
Current Oncology 2025 Nov 5;32(11):618. - Real-world comparison of survival outcomes between radical cystectomy and intravesical Bacillus Calmette-Guérin (BCG) therapy in BCG-naïve or -unresponsive non-muscle-invasive bladder cancer
- Makito Miyake, Nobutaka Nishimura, Rikiya Taoka, Jun Miki, Ryoichi Saito, Wataru Fukuokaya, Yoshiyuki Matsui, Kei Daizumoto, Yuto Matsushita, Takuji Hayashi, Junichi Inokuchi, Yusuke Sugino, Kenichiro Shiga, Noriya Yamaguchi, Shingo Yamamoto, Keiji Yasue, Naotaka Nishiyama, Hiroyuki Nishiyama, Hiroshi Kitamura, and Kiyohide Fujimoto; on behalf of the Japanese Urological Oncology Group
Int J Urol. in press - High salt-induced osmotic stress differentially modulates hepatocellular and renal carcinoma cell proliferation.
- Xi Chen, Asadur Rahman, Kento Kitada, Yaoyu Wang, Yoshihiro Nakajima, Changjin Liu, Rikiya Taoka and Akira Nishiyama
Frontiers in Oncology in press - Olaparib Plus Abiraterone in Asian Patients With Metastatic Castration-Resistant Prostate Cancer: PROpel Subset Analysis
- Mototsugu Oya, Jae Young Joung, Ji Youl Lee, Mikio Sugimoto, Young Deuk Choi, Jun Hyuk Hong, Hiroji Uemura, Kazuo Nishimura, Hideyasu Tsumura, Satoru Kawakami, Yukiyoshi Hirayama, Tae Gyun Kwon, Cheol Kwak, Hiroyoshi Suzuki, Tomoko Fujita, Masahiro Nii, David McGuinness, Melanie Dujka, Christian Poehlein, Fred Saad, Noel Clarke
Cancer Sci. 2025 Jun;116(6):1638-1647. doi: 10.1111/cas.16459. Epub 2025 Mar 18. - Olaparib Monotherapy or in Combination with Abiraterone for the Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) and a BRCA Mutation
- Fred Saad , Andrew J Armstrong , Neal Shore , Daniel J George , Mototsugu Oya , Mikio Sugimoto , Rana R McKay , Maha Hussain , Noel W Clarke
Target Oncol. 2025 May;20(3):445-466. doi: 10.1007/s11523-025-01146-4. Epub 2025 May 21. - Protocol summary of a randomized controlled phase III trial for confirming the superiority of local radiotherapy for prostate cancer patients with high-volume metastasis sensitive to hormonal therapy: the JCOG2011 (HimeRT study)
- Naoki Terada, Keiji Nihei, Rihito Aizawa, Shintaro Narita, Takahiro Kojima, Masaki Shiota, Shusuke Akamatsu, Takahiro Kimura, Takahiro Inoue, Mikio Sugimoto, Yuta Sekino, Keita Sasaki, Taro Shibata, Haruhiko Fukuda, Hiroyuki Nishiyama, Hiroshi Kitamura, Takashi Mizowaki ; Urological Oncology Study Group (UOSG) and the Radiation Therapy Study Group (RTSG) of the Japan Clinical Oncology Group (JCOG) Kamoto Toshiyuki
Jpn J Clin Oncol . 2025 Oct 6:hyaf157. doi: 10.1093/jjco/hyaf157. Online ahead of print. - Potential of Kidney Exchange Programs (KEPs) in Japan for Donor-Specific Antibody-Positive Kidney Transplants: A Questionnaire Survey on KEPs and a Multi-Institutional Study Conducting Virtual Cross- Matching Simulations
- Taihei Ito, Miki Ito, Naohiro Aida, Kei Kurihara, Akihiro Terao, Yoshihiko Watarai, Mitsuru Saito, Keizo Kaku, Daisuke Ishii, Satoshi Sekiguchi, Tatsuo Yoneda, Kohei Unagami, Masayuki Tasaki, Hitoshi Iwamoto, Motoo Araki, Kazuhiro Takahashi, Kazuaki Yamanaka, Mikio Sugimoto, Kouhei Nishikawa, Chikashi Seto, Masaki Muramatsu, Toshihiro Asai, Daiki Iwami, Yasutoshi Yamada, Shigeyoshi Yamanaga, Tomonori Komatsu, Masayoshi Miura, Takahiro Nohara, Michihiro Maruyama, Yuki Miyauchi, Toshiaki Tanaka, Michio Nakamura, Kiyohiko Hotta, Takashi Kenmochi
J Clin Med. 2025 Aug 29;14(17):6122. - Prostate-specific Antigen and Objective Response Analyses in PROpel: Olaparib Plus Abiraterone Versus Placebo Plus Abiraterone as First-line Therapy for Metastatic Castration-resistant Prostate Cancer
- Fred Saad, Andrew J Armstrong, Mototsugu Oya, Neal Shore, Giuseppe Procopio, João Daniel Guedes, Cagatay Arslan, Niven Mehra, Emma Brown, Jae Young Joung, Mikio Sugimoto, Oliver Sartor, Christian Poehlein, Elizabeth A Harrington, Jinyu Kang, Noel Clarke
Eur Urol Oncol. 2025 Nov 4:S2588-9311(25)00284-6. doi: - Successful robot-assisted resection of a retroperitoneal cystic tumor with fluorescent ureteral stent and Firefly imaging
- Yoichiro Tohi, Kana Kohashiguchi, Kenichi Tanaka, Mari Jinno
IJU case report - A case of hemophagocytic lymphohistiocytosis during immune checkpoint inhibitor treatment for metastatic renal cell carcinoma, complicated by pancytopenia attributed to cytomegalovirus infection
- Tomoko Honda, Hirohito Naito, Yu Osaki, Yoichiro Tohi, Yuki Matsuoka, Takuma Kato, Homare Okazoe, Rikiya Taoka, Nobufumi Ueda, Mikio Sugimoto
IJU Case Rep. 2025 Jun 5;8(4):423-426. - Active Surveillance and Focal Therapy in Localized Prostate Cancer from the Perspective of Organ Preservation Strategy
- Yoichiro Tohi , Mikio Sugimoto
Gan To Kagaku Ryoho. 2025 Mar;52(3):198-204.